The Gross Law Firm Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP

Core Viewpoint - Inspire Medical Systems, Inc. is facing allegations of misleading shareholders regarding the launch of its new product, Inspire V, which reportedly failed due to poor demand and inadequate preparations [1]. Group 1: Allegations and Issues - The complaint states that the launch of Inspire V was a disaster, with significant surplus inventory at providers and reluctance to transition to the new treatment [1]. - Defendants allegedly made false statements about the successful launch, while failing to complete essential tasks such as training and onboarding for treatment center customers [1]. - Critical IT systems, including customer approval processes and insurer claims software, were not properly set up, and Medicare reimbursement was not in place at the time of launch [1]. Group 2: Class Action Details - Shareholders who purchased shares of Inspire Medical Systems during the class period from August 6, 2024, to August 4, 2025, are encouraged to register for the class action [2]. - The deadline for shareholders to seek lead plaintiff status is January 5, 2026, and there is no cost or obligation to participate in the case [2].